Answer:
3
Explanation:
Heterozygous mice at both loci would be BbAa genotype.
B (black) is dominant over b (white) but the presence of A results in agouti.
Crossing two heterozygous:
BbAa x BbAa
Progeny
<em>9 B_A_ - Agouti</em>
<em>3 bbA_ - agouti</em>
<em>3 B_aa - Black</em>
<em>1 bbaa - white</em>
Hence, 3 out of 16 progeny will be black in color.
<em>See the attached image for the Punnet's square analysis of the cross.</em>
Answer:
Four innovations are central nervous system, eyes, bilateral and hermaphrodites.
Explanation:
Innovations found in an ancient flatworm were the presence of central nervous system means head and a brain. The head had eyes which is the first in the animal world. Their body is bilateral means equally divided into two parts. They are also hermaphrodites means having male and female on a single organism which was not present at that time of animals.
Both Grosz and Dos Passos were looking to animals for their understanding of humans.
Elizabeth Grosz is famous for her theory "Art and the animal" where she explains that <span> we humans take our cue from the animal world.
The American novelist Dos Passos, also believes </span>that the natural world and human civilization are essentially disparate. Their portrayals are generally positive.
<u>Stem cell </u>research has the potential to significantly impact the development of disease-modifying treatments for Parkinson’s disease with considerable progress made in creating dopamine-progressing cells.
Explanation:
Parkinson’s disease, a neurodegenerative disease, leads to reduction of dopamine (a neurochemical messenger which carries messages involving thinking and body movements to brain) in the body because the disease will target and kill dopamine-producing nerve cells (neurons). This leads to loss of movement and thinking abilities which are activated by dopamine.
Stem cells research is done to study about the prospects of stem cells in stem cell therapy for Parkinson’s patients as a viable source of new dopamine nerve cells. Research has been involved in growing stem cells to replace or regenerate dopamine-producing nerve cells by using embryonic stem cells or induced pluripotent stem cells as a treatment modality in Parkinson’s disease.
